Metabolic syndrome (MetS) refers to a cluster of metabolic dysregulations, which include
insulin resistance, obesity, atherogenic dyslipidemia and hypertension. The complex …

Background: In recent years, the lipoprotein lipase (LPL) polymorphism has been
extensively investigated as a potential risk factor for coronary artery disease (CAD) …

Metabolic syndrome (MetS) is complex and determined by the interaction between genetic
and environmental factors and their influence on obesity, insulin resistance, and related …

Adipocytes play a crucial role in the metabolism of lipids and sugars. Their response varies
depending on the circumstances or other factors influenced by physiological and metabolic …

Objective Dyslipidaemia is considered a metabolic abnormality andan important risk factor
that leads to atherogenic cardiovascular diseases. Cigarette smoking is associated with …

Lipoprotein lipase (LPL) is widely linked to lipid and lipoprotein metabolism, but its effects on
coronary artery disease (CAD) are not clearly elucidated. The aim of the present study was …

Background Peroxisome proliferator-activated receptor α (PPARα) is a nuclear transcription
factor responsible for gene expression, particularly those associated with lipid metabolism …

Background. Different common gene variants were related to coronary artery disease (CAD)
in many studies. Yet, the relation of these loci to the severity of CAD is not completely …

Background Polymorphisms in the lipoprotein lipase (LPL) and apolipoprotein CII (APO CII)
genes have been linked to severe hypertriglyceridemia in several populations. This study …

Dyslipidemia is a risk factor for the development of cardiovascular disease, the leading
cause of mortality in Saudi Arabia. Abnormal lipid levels are asymptomatic but detected by …